Here are relevant reports on : cardiology-market
-
Chemiluminescence Immunoassay Market by Product (Instruments, Consumables), Technology (CLEIA, ECLI, Microparticle CLIA), Sample Type (Blood, Saliva), Application (Oncology, Cardiology), End User (Hospital, Clinical Laboratory) - Global Forecast to 2031
The Chemiluminescence Immunoassay market, valued at US$10.89 billion in 2025, stood at US$11.58 billion in 2026 and is projected to advance at a resilient CAGR of 7.2% from 2026 to 2031, culminating in a forecasted valuation of US$16.39 billion by the end of the period. The chemiluminescence immunoassay (CLIA) market is experiencing rapid growth because increasing rates of chronic and infectious diseases create a need for precise diagnostic tests.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Ultrasound Market by Technology (2D,3D,Doppler,CEU,HIFU, ESWL), Display (Colour, B/W), Portability (Trolly, Compact,POC), Component (Linear, Phased array, Workstation), Application (OB/GYN, Cardiology, Ortho), End User (Hospitals) Global Forecasts to 2030
The global ultrasound market, valued at US$8.65 billion in 2023, stood at US$9.32 billion in 2024 and is projected to advance at a resilient CAGR of 6.8% from 2024 to 2030, culminating in a forecasted valuation of US$13.87 billion by the end of the period. The ultrasound market is experiencing significant growth due to several key factors. One major driver is the rising prevalence of chronic diseases, such as cardiovascular conditions, cancer, and musculoskeletal disorders, which require advanced diagnostic tools.
- Published: January 2025
- Price: $ 7150
- TOC Available:
-
Coronary Stent Market by Type (BMS, BVS, Drug Eluting), Mode of Delivery (Self, Balloon Expandable), Material (Metal (Stainless Steel, CoCr, PtCr, Nitinol), Polymer, Copolymer), & End User (Hospital, Cardiology Center, ASC) - Global Forecasts to 2021
The coronary stent market is projected to reach grow at a CAGR of 7.6%. Major factors driving the growth of this market include technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of CAD, increasing demand for minimally invasive procedures, and rising geriatric population.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Diagnostic Imaging Services Market Size, Growth by Procedure (MRI, Ultrasound, CT, X-RAY, Nuclear Imaging, Mammography), Application (OB/Gyn, Pelvic/Abdomen, Cardiology, Oncology, Neurology), Technology, End User (Hospitals, Diagnostic Centers) & Region - Global Forecasts to 2027
The global diagnostic imaging services market size is projected to reach USD 702.6 billion by 2027, at a CAGR of 5.1%. Prominent players in this market includes RadNet, Inc. (US), Sonic Healthcare (Australia), Akumin Inc. (US), Healius Limited (Australia), RAYUS Radiology (US), Dignity Health (US), Novant Health (US), Alliance Medical (UK), InHealth Group (UK), Apex Radiology (Australia), Concord Medical Services Holdings Limited (China), Unilabs (Switzerland), Affidea (Netherlands), I-MED Radiology Network (Australia), Capitol Imaging Services (US), SimonMed (US), among others.
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) in Medical Diagnostics Market by Modality (MRI, CT, X-ray, Ultrasound), Applications (IVD, Radiology, Cardiology, Neurology, Obstetrics/GYN), End User (Hospitals, Imaging Centers, Diagnostic Labs) & Region - Global Forecast to 2029
The global AI in medical diagnostics market, valued at US$1.33 billion in 2023, stood at US$1.71 billion in 2024 and is projected to advance at a resilient CAGR of 22.5% from 2024 to 2029, culminating in a forecasted valuation of US$4.72 billion by the end of the period. Growth in the AI in medical diagnostics market is primarily driven by the growing demand for AI tools, increasing focus on reducing the workload of radiologists, influx of large & complex datasets, funding for AI-based startups, and growing cross-industry partnerships & collaborations.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
North American Nuclear Medicine Market / Radiopharmaceuticals Market Size by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), Application (Oncology, Cardiology) & Region - Global Forecast to 2024
North american nuclear medicine market growth is primed to transition from $2.2 billion in 2019 to $2.7 billion by 2024, showcasing a strong CAGR of 4.1%. Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
Metabolomics Market by Product (GC,UPLC, CE, Surface based Mass Analysis), Application (Biomarker Discovery, Drug Discovery,Functional Genomics), Indication (Cardiology, Oncology,Inborn Errors), End User (Academic Institute,CROs) & Region - Global Forecast to 2025
The global metabolomics market in terms of revenue was estimated to be worth $1.9 billion in 2020 and is poised to reach $4.1 billion by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
Nuclear Medicine Market by Type [SPECT (Tc-99m, I-123, Ga-67), PET (F-18), Alpha Emitters, Beta Emitters (Y-90, Lu-177), Brachytherapy], Application (Oncology, Cardiology, Neurology), Procedure, End User (Imaging Center, Hospital), and Region -Global Forecast to 2030
The global nuclear medicine market, valued at USD 9.03 billion in 2024, stood at USD 10.41 billion in 2025 and is projected to advance at a resilient CAGR of 15.1% from 2025 to 2030, culminating in a forecasted valuation of USD 21.01 billion by the end of the period. The growth of the market is driven by the rising prevalence of cancer and cardiovascular diseases, which is accelerating the demand for diagnostic and therapeutic radiopharmaceuticals and medical radioisotopes.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Top 10 Medical Device Technologies Market Size, Share & Trends by Type (In Vitro Diagnostics, Diagnostics Imaging, Orthopedic, Ophthalmology, Cardiology, Endoscopy, Diabetes Care, Respiratory Care & Anesthesia, Kidney/Dialysis Devices) and Region - Global Forecast to 2027
The global Top 10 Medical Device Technologies market, valued at US$417.7 billion in 2021, stood at US$437.4 billion in 2022 and is projected to advance at a resilient CAGR of 5.7% from 2022 to 2027, culminating in a forecasted valuation of US$577.5 billion by the end of the period. This growth is driven by trends such as the shift from centralized to point-of-care testing, increasing chronic disease prevalence due to urbanization and lifestyle changes, and growing healthcare needs in emerging economies like India, China, and Brazil.
- Published: May 2023
- Price: $ 8150
- TOC Available:
-
IVD Market in BRIC by Product & Service (Instruments, Reagents, Software), Technology (Immunoassay, Hematology, Microbiology), Application (Diabetes, Cardiology, Infectious Diseases), Country (Brazil, Russia, India, China) - Global Forecast to 2022
The BRIC IVD Market and other emerging countries is expected to reach USD 15.71 Billion by 2022 from USD 10.60 Billion in 2017, at a CAGR of 8.2%. The key factors driving the growth of the market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers, and improving healthcare system in emerging countries. However, market growth is restrained by the lack of reimbursement and the slow growth of the economy in some emerging countries.
- Published: May 2017
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
